ALL PCR Panel (BCR-ABL, TEL-AML1, MLL, E2A) — 1,500 AED | Dubai Healthcare City

Executive Summary & Core Metrics

Comprehensive Cytogenetic Risk Stratification for Acute Lymphoblastic Leukaemia

The ALL PCR Panel delivers high‑precision detection of four critical genetic rearrangements — BCR‑ABL, TEL‑AML1, MLL, and E2A — enabling risk‑directed therapy selection and minimal residual disease monitoring. Processing is conducted under ISO‑accredited protocols with a diagnostic sensitivity exceeding 99.9%. Clinical interpretation is provided by our Consultant Medical Genetics team.

Accuracy Guarantee
99.9% Diagnostic Sensitivity (qPCR + WGS) via ISO‑Accredited Processing

Premium Logistics
Hospital‑Grade Home Collection with ISO Cold‑Chain & VIP Mobile Phlebotomy

Clinical Guidance
Telephonic Post‑Test Clinical Interpretation from Senior Medical Team

Insurance
Direct Billing Verification via WhatsApp
+971 54 548 8731

Test Overview & Methodology

The ALL PCR Panel is a high‑precision molecular diagnostic test that detects four critical cytogenetic abnormalities — BCR‑ABL, TEL‑AML1, MLL, and E2A — frequently implicated in acute lymphoblastic leukaemia, enabling risk stratification and targeted therapy selection. Results are correlated with complete blood counts and flow cytometry to provide an integrated clinical picture.

Feature	Our ALL PCR Panel	Closest Alternative
Genetic Markers	4 targets: BCR‑ABL, TEL‑AML1, MLL, E2A	Single marker (e.g., BCR‑ABL only)
Methodology	Real‑Time PCR (qPCR) + confirmatory WGS	Conventional PCR (lower resolution)
Turnaround Time	5–6 working days	7–10 working days
Accreditation	ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139)	Variable; often non‑accredited
Sample Collection	Hospital extraction only — sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety	Hospital visit only; extended transport times for bone marrow specimens
Post‑Test Support	Included telephonic clinical guidance	Limited or none

Physician Insight & Safety Protocols

As a Consultant Medical Genetics specialist, I understand the profound anxiety that accompanies a leukaemia workup. This PCR panel provides essential cytogenetic data that drives modern, personalised therapy. However, these results must always be correlated with complete clinical findings; never self‑interpret the report, and maintain close communication with your haematologist for coordinated care.

— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403

Medication Advisory Notice

Do not discontinue any prescribed medication without consulting your doctor. Genetic test results are not a sole basis for changing treatment. All therapeutic decisions must be made by your treating haematologist or oncologist following a complete clinical evaluation.

Exclusion Criteria & Emergency Red Flags

Immediate cold‑chain transport of bone marrow or peripheral blood is mandatory; if this cannot be ensured, the test cannot be processed.
Active infection at the phlebotomy site or platelet count <20,000/µL contraindicates blood draw — medical clearance required.
Emergency Warning: If you develop high fever, uncontrolled bleeding, severe bone pain, or signs of infection, seek emergency care immediately. This test is not designed for acute crisis management.

Patient FAQ & Clinical Guidance

1. What is the ALL PCR Panel and what does it detect?

Direct Answer: The ALL PCR Panel detects four key genetic abnormalities — BCR‑ABL, TEL‑AML1, MLL, and E2A — commonly found in acute lymphoblastic leukaemia, aiding diagnosis, risk stratification, and targeted therapy selection. This comprehensive approach helps haematologists personalise treatment and monitor minimal residual disease over time.

2. How is the test performed and what is the turnaround time?

Direct Answer: The test requires a bone marrow aspirate or peripheral blood sample collected exclusively within an accredited hospital setting; results are delivered within 5–6 working days via secure online portal with telephonic guidance from our Consultant Medical Genetics team. The sample is transported under strict ISO‑certified cold‑chain conditions for maximum accuracy.

3. Is this test covered by health insurance in the UAE?

Direct Answer: Yes, we support direct billing verification through WhatsApp +971 54 548 8731; most UAE insurers cover genetic leukaemia panels when medically necessary. Our team will help you obtain pre‑approval and clarify any co‑payment before the test is scheduled.

4. Do I need a doctor’s prescription to proceed?

Direct Answer: Yes, a valid doctor’s prescription is mandatory for all genetic and molecular oncology tests. The requesting physician must complete the clinical indication form to ensure appropriate test selection and insurance pre‑approval.

UAE Regulatory & Data Privacy Adherence

Legal & Compliance Framework

Data Protection: All genetic and clinical data are processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
Health Information Governance: Electronic health records and test results are managed per Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Clinical Safety & Consent: Patient consent and medical liability protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) — all laboratory processes are independently audited.
Direct Billing: Insurance verification available via WhatsApp +971 54 548 8731.

Clinical & Logistical Metadata

Test Name	ALL PCR Panel (BCR-ABL, TEL-AML1, MLL, E2A)
Price (AED)	1,500
Turnaround Time	5–6 Working Days
Sample Type / Matrix	Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety
Methodology Used	Real-Time PCR (qPCR) + Confirmatory Whole Genome Sequencing (WGS)
ICD-10-CM Code	C91.00, Z15.01, Z82.79
LOINC Code	49873-3
DHA Facility License & Laboratory Address	DHA License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE